citiusonc.com (CTOR) Cash Funds Calculated per Share

Citius Oncology Inc - graphic logo of issuer CTOR

Citius Oncology, Inc. (CTOR) is establishing a cutting-edge immunotherapy environment by integrating Lymphir into treatment protocols for rare lymphomas. The current cash per share clearly demonstrates the issuer's liquidity, with the 0.18 mark recording this metric. A highly skilled workforce incentivized by stock options, combined with the market launch of innovative products, ensures the company's steady growth within the oncology niche.

Citius Oncology, Inc. (CTOR) - Cash Funds per Share from 08/14/2024 to 11/20/2026

Comprehensive metric breakdowns and analytics for Citius Oncology Inc. (CTOR)

- price and consensus price forecast:
- cash availability and cash flow indicators:
Comprehensive company analysis:CTOR (Citius Oncology Inc)
Product sample of Citius Oncology

Commercializing a unique biologic for the treatment of cutaneous lymphoma requires significant resources; therefore, calculating liquid reserves per share allows for an assessment of the financial stability of Citius Oncology, Inc. (CTOR) during its expansion period. An analysis of cash per share demonstrates the balance between defensive capital and the risk of underutilizing funds, determining the company's ability to maintain its orphan status without emergency shareholder dilution.

Analysis of competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash Funds Calculated per Share tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Cash Funds per Share|FATE: Cash Calculated per Single Share|WHWK (Aadi Bioscience, Inc.) - Cash per Share|TCRX (TScan Therapeutics) - Cash Calculated per Single Share|Cash Funds per Share Champions Oncology (CSBR)|Cash Funds Calculated per Share XBiotech USA|Cash Funds per Share CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Cash on Hand per Share|RADX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com